Andrea Espinoza, MD
Pulmonary Disease · Houma, LANPI 1700839495
Payments from drug & device makers
Across 710 payments — averaging $922.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$389K
- Regeneron Healthcare Solutions, Inc.$140K
- Sanofi$122K
- Boehringer Ingelheim$897
- GSK$699
- Grifols USA, LLC$381
- plus $1K from 15 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 396 | $389,215 |
| Regeneron Healthcare Solutions, Inc. | 130 | $139,928 |
| Sanofi | 70 | $122,212 |
| Boehringer Ingelheim | 12 | $897 |
| GSK | 34 | $699 |
| Grifols USA, LLC | 16 | $381 |
| Sunovion Pharmaceuticals Inc. | 19 | $295 |
| Tactile Systems Technology Inc | 2 | $265 |
| Insmed, Inc. | 5 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $75 |
| Novartis | 3 | $73 |
| Genentech USA, Inc. | 3 | $72 |
| Viatris Specialty LLC | 3 | $66 |
| Philips North America LLC | 4 | $62 |
| Baxter Healthcare | 3 | $58 |
| Mylan Specialty L.p. | 3 | $56 |
| Electromed, Inc. | 2 | $41 |
| Advanced Respiratory, Inc | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Verona Pharma, Inc. | 1 | $15 |
How this compares
$654,731 in reported general payments places this provider in the 95th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Houma
- David GreenShreveport$2M
- Joseph LaskyNew Orleans$1.9M
- Leonardo SeoaneNew Orleans$1.6M
- Ross KlingsbergNew Orleans$1.2M
- Juzar AliNew Orleans$775K
- Hollis O NealBaton Rouge$682K
- Ramsy AbdelghaniNew Orleans$474K
- Bennett DeboisblancNew Orleans$457K
- Nereida ParadaNew Orleans$289K
- Alexander MulamulaBaton Rouge$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.